Edison International (EIX) 10-Q2023 Q3 Quarterly report

Filed: 1 Nov 23, 4:11pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Bad

New words: automatically, bench, bilateral, CRR, cycle, delivery, earlier, embedded, expansion, Kara, LAFD, lapse, lease, mild, Perpetual, plaintiff, PPA, protest, ratification, recast, Ryan, SBLC, shut, standby, tender, tendered, uncommitted, whichever

Removed: adjust, billed, CEMA, deadline, delayed, demonstrate, failed, growth, mature, prejudice, repair, replace, restore, Rye, segregate, segregating, submit, summer, testimony

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated EIX transcripts

EIX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

STATEMENT PURSUANT TO 18 U.S.C. SECTION 1350, AS

ENACTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the "Quarterly Report"), of Edison International (the "Company"), and pursuant to 18 U.S.C. Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies, to the best of his or her knowledge, that:

The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2023


	/s/ PEDRO J. PIZARRO
	PEDRO J. PIZARRO Chief Executive Officer Edison International

	/s/ MARIA RIGATTI
	MARIA RIGATTI Chief Financial Officer Edison International

This statement accompanies the Quarterly Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.